Riskpilot← Back to searchSign inGet full accessVitaelab AB
ABDissolvedOrg 5567501928Wholesale of other food · NACE 4638Est. 20080 employees
Revenue 2022
SEK 134,9M
+2% vs 2021
EBITDA margin
17.2%
-9% vs 2021
Equity ratio
22.0%
Financial strength
Net profit 2022
SEK 12,1M
-1% vs 2021
| Revenue | SEK 134,9M | +2% |
| EBITDA | SEK 23,3M | -9% |
| Net profit | SEK 12,1M | -1% |
| Total assets | SEK 63,4M | +5% |
| Equity | SEK 13,9M | -17% |
| Employees | 0 | — |
Legal name
Vitaelab AB
Org number
5567501928
Legal form
Aktiebolag
NACE code
4638 · Wholesale of other food
Founded
22 januari 2008
Share capital
SEK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2022-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget ska bedriva import, export och försäljning av kosttillskott och liknande produkter samt därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Revenue | 109 264 | 107 788 | — | 132 752 | 134 930 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 25 769 | 25 197 | 0 | 25 593 | 23 256 |
| Depreciation & amort. | −104 | −0 | — | −0 | −0 |
| EBIT | 25 665 | 25 197 | 0 | 25 593 | 23 256 |
| Net financials | −388 | −162 | — | −35 | 630 |
| Profit before tax | 24 629 | 18 748 | 0 | 15 460 | 15 328 |
| Tax | −5 445 | −4 037 | — | −3 217 | −3 194 |
| Net profit | 19 184 | 14 711 | — | 12 243 | 12 134 |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Total assets | 52 313 | 48 856 | — | 60 342 | 63 391 |
| Equity | 23 555 | 20 266 | — | 16 793 | 13 927 |
| Long-term debt | 0 | 0 | — | 0 | 0 |
| Short-term debt | 12 813 | 6 357 | — | 8 290 | 9 028 |
| Total debt | 12 813 | 6 357 | — | 8 290 | 9 028 |
EBITDA margin
17.2%
This company
15.8%
Market median
+9% vs market
20182022
Equity ratio
22.0%
This company
38.2%
Market median
-42% vs market
20182022
Return on equity
87.1%
This company
18.4%
Market median
+373% vs market
20182022
Net profit margin
9.0%
This company
8.1%
Market median
+11% vs market
20182022
Asset turnover
2.13×
This company
1.12×
Market median
+90% vs market
20182022
Debt / equity
3.55×
This company
0.62×
Market median
-473% vs market
20182022
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
AK Authorized Recipient of Service | Authorized Recipient of Service | 2022 |
AE Chief Auditor | Chief Auditor | 2022 |
| Former (1) | ||
LM Chief Auditor | Chief Auditor | 2022 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2022 | |
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Vitaelab AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Leif Mattias Celind | Chief Auditor | 0 companies |
| Anette Kristiina Kaisla | Authorized Recipient of Service | 0 companies |
| Annika Elisabeth Engström | Chief Auditor | 0 companies |
| Gustaf Solerød Christensen | Chairman | 0 companies |
| Marius Alexander Skovli | Board of Directors | 0 companies |
| Rolf Erik Sjöqvist | Deputy Board Member | 0 companies |